A5079572912- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
- Cardiac pacing and defibrillation studies
- ECG Monitoring and Analysis
- Cardiovascular Syncope and Autonomic Disorders
- Vascular anomalies and interventions
- Neurological Disorders and Treatments
- Healthcare Systems and Public Health
- Plant-based Medicinal Research
National Medical Research Center of Cardiology
2021
North-Western State Medical University named after I.I. Mechnikov
2013
Aim. We aimed to assess safety and effectiveness of class III antiarrhythmic drug Refralon for conversion atrial fibrillation (AFib) flutter (AFl) in post-registration trial compare data primary center (National medical research cardiology) with other hospitals. Material Methods . performed retrospective cohort study 727 patients (451 enrolled 276 hospitals) admitted between June 24, 2014 2019. was administered AFib AFl intense care units escalating doses (10-30 mcg/kg) intravenously....
A new dosage form of lappaconitine hydrobromide has been created – the long-acting drug Allaforte®, which fewer side effects compared to traditional (Allapinin®). Objective. To evaluate effectiveness, safety and tolerability Allaforte® therapy in comparison with Rytmonorm® patients paroxysmal atrial fibrillation (AF). Material methods. Patients who met inclusion criteria those did not meet non-inclusion were randomized into 2 groups: 1st (n=50) received 25 mg 3 times a day an increase dose...
Aim. We aimed to assess safety and effectiveness of class III antiarrhythmic drug Refralon for conversion atrial fibrillation (AFib) flutter (AFl) in post-registration trial compare data primary center (National medical research cardiology) with other hospitals. Material Methods . performed retrospective cohort study 727 patients (451 enrolled 276 hospitals) admitted between June 24, 2014 2019. was administered AFib AFl intense care units escalating doses (10-30 micrograms/kg) intravenously....
Most cardiovascular diseases (CVD) are of atherosclerotic origin, and lipid disorders play significant role, setting up the continuum, together with other risk factors. It also known that decrease low density lipoproteins cholesterol (CLDL) level leads to decreased occurrence CVDs in primary secondary prevention diseases. Statins, at moment, a standard medical care. However, two problems remain on way reduction — insufficient statins prescription rate archived target levels CLDL. In end...
The indications for Holter monitoring, which are included in the new Russian guidelines on cardiac arrhythmias and conduction disturbances, considered. Possibilities of diagnostic approaches arrhythmias, management algorithms treatment efficacy safety monitoring discussed.
Purpose: This study evaluated the impact of elimination Adenosine-Triphospatis (ATP)-induced dormant Pulmonary Vein (PV) conduction on clinical outcome after PV isolation in patients with Atrial Fibrillation (AF). Methods: Study included 134 paroxysmal (25%) and persistent (75%)AF. After antral isolation, 30 minutes observation period was applied. All acute reconnections were eliminated then ATP-test performed to reveal conduction. In case randomized 2 groups. Dormant by additional ablations...